Sotera Health Company (SHC)

Market Cap	3.74B
Revenue (ttm)	1.12B
Net Income (ttm)	70.49M
Shares Out	283.24M
EPS (ttm)	0.25
PE Ratio	52.93
Forward PE	17.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,406,449
Open	13.45
Previous Close	13.61
Day's Range	12.63 - 13.48
52-Week Range	10.71 - 17.44
Beta	2.08
Analysts	Buy
Price Target	16.50 (+24.91%)
Earnings Date	Nov 5, 2024

About SHC

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, re...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 20, 2020
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: SHC
• Website: https://soterahealth.com

Analyst Forecast

According to 6 analysts, the average rating for SHC stock is "Buy." The 12-month stock price forecast is $16.5, which is an increase of 24.91% from the latest price.

Price Target

$16.5

(24.91% upside)

Analyst Consensus: Buy